🇮🇳 H5G1.1 in India

H5G1.1 (ECULIZUMAB) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

H5G1.1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in India

Frequently asked questions

Is H5G1.1 approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for H5G1.1 in India?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.